NCT07013188 Characterising the Neuromuscular Function of Post Stroke Patients
| NCT ID | NCT07013188 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Nottingham |
| Condition | Stroke (CVA) or TIA |
| Study Type | OBSERVATIONAL |
| Enrollment | 16 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 16 participants in total. It began in 2024-06-01 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Strokes are a leading cause of death and disability in developed countries, with significant economic and social impacts. Defined by the WHO, strokes cause rapid and lasting disturbances in cerebral function. In the UK, strokes occur every five minutes, affecting 100,000 people annually and resulting in substantial physical impairments and financial costs. Although stroke-related deaths have decreased due to improved treatments and awareness, strokes remain a major cause of death and disability worldwide, especially in lower-income countries. Strokes typically cause unilateral deficits, leading to significant daily challenges and necessitating tailored rehabilitation strategies such as CIMT, FES, and VR Rehab. As the population ages, innovative neurorehabilitation approaches are essential to enhance functional recovery post-stroke. This pilot study aims to better understand the neuromuscular deficits caused by stroke to inform and improve future rehabilitation interventions, including the potential use of force accuracy training (FAT)
Eligibility Criteria
Inclusion Criteria: * • Aged between 40-85 years * Willing and able to give informed consent for participation in the study * Had a confirmed stroke within the last 5 years * Self-reports persisting post-stroke loss of unilateral limb function Exclusion Criteria: * • Diagnosis of cognitive impairment/dementia * Current or recent (\<2y) malignancy * Severe respiratory disease (e.g., uncontrolled asthma, COPD, pulmonary hypertension) * Active cardiovascular disease: Uncontrolled hypertension (BP\>160/100mmHg); Recent (\<12mo) cardiac event; Heart failure (Class III/IV); Significant arrhythmia; Unstable angina * Metabolic disease: Untreated hyper/hypoparathyroidism; Cushing's disease * Significant musculoskeletal disorders (based on clinical opinion) * Dialysis patients * Recent steroid treatment within 6 months or hormone replacement therapy * Mobility dependant (wheelchair dependency)
Frequently Asked Questions
Who can join the NCT07013188 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 85 Years, studying Stroke (CVA) or TIA. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07013188 currently recruiting?
Yes, NCT07013188 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Nottingham to inquire about joining.
Where is the NCT07013188 trial being conducted?
This trial is being conducted at Derby, United Kingdom.
Who is sponsoring the NCT07013188 clinical trial?
NCT07013188 is sponsored by University of Nottingham. The trial plans to enroll 16 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.